First Trust Direct Indexing’s Jazz Pharmaceuticals JAZZ Stock Holding History

First Trust Direct Indexing’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,917	Closed	-$214K	–	463
2024 Q3	$214K	Sell	1,917 -1,045	-35%	-$115K	0.01%	894
2024 Q2	$316K	Buy	2,962 +222	+8%	+$24.4K	0.02%	652
2024 Q1	$330K	Buy	2,740 +962	+54%	+$118K	0.02%	588
2023 Q4	$219K	Buy	1,778 +173	+11%	+$21.6K	0.02%	683
2023 Q3	$208K	Buy	+1,605	New	+$214K	0.02%	638
2021 Q3	–	Sell	-2,446	Closed	-$435K	–	667
2021 Q2	$435K	Buy	2,446 +186	+8%	+$32.2K	0.06%	356
2021 Q1	$371K	Sell	2,260 -103	-4%	-$16.9K	0.1%	269
2020 Q4	$390K	Buy	+2,363	New	+$352K	0.11%	238

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Trust Direct Indexing's JAZZ Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2024, closing a stake of 1,917 shares — an estimated $214K sold.

First Trust Direct Indexing first reported a position in JAZZ in Q4 2020 and held it in 8 quarters. The position peaked at $435K in Q2 2021. 508 funds tracked by Wall St. Rank hold JAZZ as of Q4 2024.

First Trust Direct Indexing reported no remaining Jazz Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
First Trust Direct Indexing sold 1,917 Jazz Pharmaceuticals shares in Q4 2024, an estimated $214K.
First Trust Direct Indexing first reported a position in Jazz Pharmaceuticals in Q4 2020 and held it in 8 quarters.
First Trust Direct Indexing's Jazz Pharmaceuticals position peaked at $435K in Q2 2021.
508 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.